Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord blood SARS-CoV-2 antibody levels in newborns of mothers vaccinated during pregnancy
TCTR20230125004Phase 2Completed
- Sponsor
- Chiang Mai University
- Start
- Aug 2022
- Countries
- 1
01
Overview
Phase 2, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Chiang Mai University. Primary endpoint: Umbilical cord blood SARS-CoV-2 antibody level. Started Aug 2022; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20230125004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230125004.